{"id":"NCT02006732","sponsor":"Boehringer Ingelheim","briefTitle":"Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)","officialTitle":"A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2014-10","completion":"2014-11","firstPosted":"2013-12-10","resultsPosted":"2016-01-20","lastUpdate":"2016-01-20"},"enrollment":809,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"tiotropium + olodaterol low dose","type":"EXPERIMENTAL"},{"label":"tiotropium + olodaterol high dose","type":"EXPERIMENTAL"},{"label":"tiotropium","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to assess the efficacy and safety of 12 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC (delivered by the Respimat inhaler) compared with tiotropium and placebo in patients with COPD.","primaryOutcome":{"measure":"FEV1 AUC0-3h Response","timeFrame":"baseline and 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.006,"sd":0.014},{"arm":"Tiotropium 5 μg","deltaMin":0.188,"sd":0.013},{"arm":"Tiotropium 2.5 μg+ Olodaterol 5 μg","deltaMin":0.279,"sd":0.014},{"arm":"Tiotropium 5 μg + Olodaterol 5 μg","deltaMin":0.293,"sd":0.013}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"0.4499"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":78,"countries":["United States","Australia","Austria","Canada","Germany","Greece","New Zealand","Norway","Slovakia","South Africa","Sweden"]},"refs":{"pmids":["32671684","32462607","27316465","26320402"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":202},"commonTop":["Chronic obstructive pulmonary disease","Cough","Dyspnoea"]}}